BANAMINE- flunixin meglumine injection Estats Units - anglès - NLM (National Library of Medicine)

banamine- flunixin meglumine injection

merck sharp & dohme - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin 50 mg in 1 ml - indications horse: banamine (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: banamine (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. banamine is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostag

FLUNIXIN MEGLUMINE INJECTABLE SOLUTION- flunixin meglumine injection Estats Units - anglès - NLM (National Library of Medicine)

flunixin meglumine injectable solution- flunixin meglumine injection

covetrus - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - horse:  flunixin meglumine injectable solution is recommended for the alleviation of inflammation and pain associated with muscoskeletall disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: flunixin meglumine injectable solution is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. flunixin meglumine injectable solution is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of stillbirth. do not use flunixin meglumine injectable solution within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration are suspected. safety horse: a 3-fold intramuscular dose of 1.5 mg/lb of body weight daily for 10 consecutive days was safe. no changes were observed in hematology, serum chemistry, or urinalysis values. intravenous dosages of 0.5 mg/lb daily for 15 days; 1.5 mg/lb daily for 10 days; and 2.5 mg/lb daily for 5 days produced no changes in blood or urine parameters. no injection site irritation was observed following intramuscular injection of the 0.5 mg/lb recommended dose. some irritation was observed following a 3-fold dose administered intramuscularly. cattle: no flunixin-related changes (adverse reactions) were noted in cattle administered a 1x (2.2 mg/kg; 1.0 mg/lb) dose for 9 days (three times the maximum clinical duration). minimal toxicity manifested itself at moderately elevated doses (3x and 5x) when flunixin was administered daily for 9 days, with occasional findings of blood in the feces and/or urine. discontinue use if hematuria or fecal blood are observed.

FLUMAV FLUNIXIN INJECTION Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

flumav flunixin injection

mavlab pty. ltd. - flunixin as flunixin meglumine - parenteral liquid/solution/suspension - flunixin as flunixin meglumine benzene active 50.0 mg/ml - musculoskeletal system - cow | dog | horse | pigs | bitch | boar | bovine | castrate | colt | donkey | endurance horse | female cattle | filly | foal | g - agalactia | analgesic | anti-inflammatory agent | antipyretic | arthritis | canine parvovirus | disc problems | downer cow syndrome | infections of the respiratory tract | mastitis | metritis | musculoskeletal conditions | acute respiratory infections | antipyretic | arthritis | arthrosis | bone soreness | bronchiseptica | bronchitis | bruising | bursitis | colic | disc pain | external myopathy | inflamation of soft tissues an | inflammatory rheumatic arthrit | joint disease | ligament sprains | mastitis-metritis-agalactia | muscle relaxant | muscle soreness | osteitis | osteoarthritis | parvovirus | pharyngitis | platelet activity | pneumonia | rheumatism | sedative | spasmolytic | sprains | strains | subclinical mastitis | tendon and ligament sprains | tendon sprains | tendonitis | tenosynovitis | tonsillitis | traumatic joint and connective | traumatic swelling | vertebrae pain | vertebrae problems

POLI-FLUNARIN CAPSULE 5 mg Singapur - anglès - HSA (Health Sciences Authority)

poli-flunarin capsule 5 mg

md pharmaceuticals pte. ltd. - flunarizine hcl eqv flunarizine - capsule - 5 mg - flunarizine hcl eqv flunarizine 5 mg

FLUNIXIN MEGLUMINE Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

flunixin meglumine

neove pharma australia pty limited - flunixin meglumine - unknown - flunixin meglumine benzene active 0.0 - active constituent

Flunixin Meglumine Austràlia - anglès - APVMA (Australian Pesticides and Veterinary Medicines Authority)

flunixin meglumine

mavlab pty. ltd. - flunixin meglumine - unknown - flunixin meglumine benzene active 0.0 - active constituent

NOVO-FLUNARIZINE - CAP 5MG CAPSULE Canadà - anglès - Health Canada

novo-flunarizine - cap 5mg capsule

novopharm limited - flunarizine (flunarizine hydrochloride) - capsule - 5mg - flunarizine (flunarizine hydrochloride) 5mg - piperazine derivatives

FLUNAZINE- flunixin meglumine paste Estats Units - anglès - NLM (National Library of Medicine)

flunazine- flunixin meglumine paste

bimeda inc. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - indications: flunazine equine paste is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. activity: flunixin meglumine is a potent, nonnarcotic, nonsteroidal, analgesic agent with anti-inflammatory and antipyretic activity. it is significantly more potent than pentazocine, meperidine, and codeine as an analgesic in the rat yeast paw test. oral studies in the horse show onset of flunixin activity occurs within 2 hours of administration. peak response occurs between 12 and 16 hours and duration of activity is 24 to 36 hours.

Flunixin 50 mg/ml Solution for Injection for Cattle, Horses and Pigs Regne Unit - anglès - VMD (Veterinary Medicines Directorate)

flunixin 50 mg/ml solution for injection for cattle, horses and pigs

norbrook laboratories limited - flunixin - solution for injection - anti inflammatory nsaid - cattle, horses, pigs

BANAMINE- flunixin meglumine solution Estats Units - anglès - NLM (National Library of Medicine)

banamine- flunixin meglumine solution

merck sharp & dohme corp. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin 50 mg in 1 ml - indications: banamine transdermal pour-on is indicated for the control of pyrexia associated with bovine respiratory disease and acute bovine mastitis, and the control of pain associated with foot rot in beef cattle 2 months of age and older and dairy cattle. not for use in beef and dairy bulls intended for breeding over 1 year of age, replacement dairy heifers over 20 months of age, dry dairy cows, dairy calves, or veal calves. contraindications: nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of stillbirth. do not use banamine transdermal pour-on within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine.